Top

Published in:

01-03-2008 | Original

Percutaneous Transluminal Coronary Angioplasty for Coronary Arterial Stenosis in a 10-Year-Old Boy with Kawasaki Disease and a Brief Review

Authors: Meng-Luen Lee, Chien-Hsun Hsia

Published in: Pediatric Cardiology | Issue 2/2008

Abstract

A 10-year-old boy developed coronary artery stenosis 9 years after suffering Kawasaki disease with coronary artery aneurysms at the age of 7 months old. Percutaneous transluminal coronary angioplasty was performed successfully to dilate the coronary arteries in order to prevent obstruction of the coronary arteries.

AHA Committee Report (1975) A reporting system on patients evaluated for coronary artery disease. Circulation 51:5–40

Akagi T, Ogawa S, Ino T, et al. (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 137:181–186PubMedCrossRef

Capannari TE, Daniels S, Meyer RA, Schwartz DC, Kaplan S (1986) Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7:355–360PubMed

Echigo S (1988) PTCA in Kawasaki disease. In: Abstracts of the 3rd International Kawasaki Disease Symposium, Tokyo, p 64

Fukuda T, Akagi T, Ishibashi M, Inoue O, Sugimura T, Kato H (1998) Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. Am Heart J 135:482–487PubMedCrossRef

Hiraishi S, Misawa H, Takeda N, et al. (2000) Transthoracic ultrasonic visualization of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart 83:400–405PubMedCrossRef

Ino T, Akimoto K, Ohkubo M, et al. (1996) Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation 93:1709–1715PubMed

Ino T, Nishimoto K, Akimoto K, et al. (1991) Percutaneous transluminal coronary angioplasty for Kawasaki disease: a case report and literature review. Pediatr Cardiol 12:33–35PubMedCrossRef

Ishii M, Himeno W, Sawa M, et al. (2002) Assessment of the ability of myocardial contrast echocardiography with harmonic power Doppler imaging to identify perfusion abnormalities in patients with Kawasaki disease at rest and during dipyridamole stress. Pediatr Cardiol 23:192–199PubMedCrossRef

10.

Ishii M, Ueno T, Ikeda H, et al. (2002) Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease. Quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 105:3004–3010PubMedCrossRef

11.

Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108:923–927PubMedCrossRef

12.

Kato H, Ichinose E, Yoshioka F, et al. (1982) Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 49:1758–1766PubMedCrossRef

13.

Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H (1992) Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 340:1127–1129PubMedCrossRef

14.

Kato H, Sugimura T, Akagi T, et al. (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMed

15.

Kondo C, Hiroe M, Nakanishi T, Takao A (1989) Detection of coronary artery stenosis in children with Kawasaki disease: usefulness of pharmacologic stress Tl-201 myocardial tomography. Circulation 80:615–624PubMed

16.

Kuramochi Y, Ohkubo T, Takechi N, Ogawa S (2001) Feasibility of percutaneous transluminal coronary angioplasty to patients with Kawasaki disease as an early management strategy. Pediatr Cardiol 22:183–188PubMedCrossRef

17.

Nakano H, Ueda K, Saito A, Nojima K (1985) Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56:846–851PubMedCrossRef

18.

Nishimura H, Sawada T, Azuma A, et al. (1992) Percutaneous transluminal coronary angioplasty in a patient with Kawasaki disease. A case report of an unsuccessful angioplasty. Jpn Heart J 33:869–873PubMed

19.

Ogawa S, Fukazawa R, Ohkubo T, et al. (1997) Silent myocardial ischemia in Kawasaki disease. Evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation 96:3384–3389PubMed

20.

Pahl E, Ettedgui J, Neches WH, Park SC (1989) The value of angiography in the follow-up of coronary involvement in mucocutaneous lymph node syndrome (Kawasaki disease). J Am Coll Cardiol 14:1318–1325PubMedCrossRef

21.

Sugimura T, Yokoi H, Sato N, et al. (1997) Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation 96:3928–3933PubMed

22.

Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K (1994) Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 74:822–824PubMedCrossRef

23.

Suzuki A, Kamiya T, Kuwahara N, et al. (1986) Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 7:3–9PubMedCrossRef

24.

Tatara K, Kusakawa S (1987) Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr 111:705–710PubMedCrossRef

25.

Taubert KA, Rowley AH, Shulman ST (1994) Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 13:704–708PubMedCrossRef

26.

Tsuda E, Kamiya T, Kimura K, Ono Y, Echigo S (2002) Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol 23:9–14PubMedCrossRef

27.

Tsuda E, Kamiya T, Ono Y, Kimura K, Kurosaki K, Echigo S (2005) Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameters during Kawasaki disease. Pediatr Cardiol 26:73–79PubMedCrossRef

Title: Percutaneous Transluminal Coronary Angioplasty for Coronary Arterial Stenosis in a 10-Year-Old Boy with Kawasaki Disease and a Brief Review
Authors: Meng-Luen Lee
Chien-Hsun Hsia
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: Pediatric Cardiology / Issue 2/2008
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-007-9087-x

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Percutaneous Transluminal Coronary Angioplasty for Coronary Arterial Stenosis in a 10-Year-Old Boy with Kawasaki Disease and a Brief Review

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2008

Competition Between Native Flow and Graft Flow After Coronary Artery Bypass Grafting. Impact on Indications for Coronary Artery Bypass Grafting for Localized Stenosis with Giant Aneurysms Due to Kawasaki Disease

Transthoracic Echo-Doppler Assessment of Coronary Microvascular Function Late after Kawasaki Disease

Feeding Difficulties and Growth Delay in Children with Hypoplastic Left Heart Syndrome versus d-Transposition of the Great Arteries

Ventricular Tachycardia in Acute Fulminant Myocarditis: Medical Management and Follow-up

Clinical Investigation of Systemic-Pulmonary Collateral Arteries

Ruptured Sinus of Valsalva: Unexpected Finding in a Patient Diagnosed with Ventricular Septal Defect with Aortic Regurgitation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page